Physician profile
Bj Ho
NPI 1912105420
$134,112.30
in general payments reported to CMS, 2019-2025
24 companies · $388 in 2025
The $388 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24K · 2020: $40K · 2021: $35K · 2022: $33K · 2023: $811 · 2024: $910 · 2025: $388.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,110.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,109.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $130,414.76 | 2019-2025 | |
| Scynexis, INC. | $1,154.72 | 2022 | |
| Coopersurgical, INC. | $478.09 | 2021-2025 | Summit Doppler, Paragard T 380a, Paragard T 380a |
| Organon LLC | $319.49 | 2024 | |
| Astellas Pharma US INC | $237.17 | 2024-2025 | Veozah |
| Mayne Pharma Commercial LLC | $229.37 | 2023-2025 | |
| Ethicon US, LLC | $186.44 | 2019-2022 | |
| Hologic Sales and Service, LLC | $171.95 | 2022-2025 | Aptima, Myosure Tissue Removal Device, Novasure |
| Gynesonics, INC. | $124.99 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Minerva Surgical, INC | $119.17 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $112.38 | 2019-2025 | |
| Alexion Pharmaceuticals, INC. | $106.32 | 2019 | |
| Viiv Healthcare Company | $105.44 | 2023 | Apretude |
| Channel Medsystems, INC. | $78.18 | 2023 | |
| Medtronic, INC. | $63.04 | 2023-2024 | Interstim, Micra |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $54.09 | 2023-2024 | |
| Merz North America, INC. | $37.26 | 2025 | |
| Aspira Women'S Health INC | $22.49 | 2024 | Ova1 |
| Therapeuticsmd, INC. | $21.01 | 2022 | |
| Sumitomo Pharma America, INC. | $18.33 | 2023 | Myfembree |
| Optumhealth Care Solutions, LLC | $16.07 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Exeltis, USA INC. | $15.34 | 2025 | Slynd |
| Shield Therapeutics INC | $14.75 | 2023 | Accrufer |
| Amag Pharmaceuticals, INC. | $11.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bj Ho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.